98 related articles for article (PubMed ID: 3751793)
1. [Urine polyamine in patients with malignant urological diseases using a polyamine-test enzyme kit].
Sakai S; Koide T; Ito Y; Tei K; Deguchi T; Matsuda S; Kato N; Ban Y; Nishiura T
Hinyokika Kiyo; 1986 May; 32(5):661-5. PubMed ID: 3751793
[TBL] [Abstract][Full Text] [Related]
2. [Detection of urinary polyamine by a new enzymatic differential assay. (III). Studies on urinary polyamines in patients with malignant genitourinary diseases].
Sakai S; Ito Y; Koide T; Tei K; Hara A; Sawada H
Hinyokika Kiyo; 1986 Mar; 32(3):343-50. PubMed ID: 2425608
[TBL] [Abstract][Full Text] [Related]
3. [The clinical value of urinary polyamine analysis in urological disease].
Matsuda M; Seguchi T; Sugao H; Nakano E; Okuyama A; Sonoda T
Hinyokika Kiyo; 1988 Oct; 34(10):1703-10. PubMed ID: 3245519
[TBL] [Abstract][Full Text] [Related]
4. [Detection of urinary polyamine by a new enzymatic differential assay. (II). Comparison with conventional method].
Sakai S; Ito Y; Koide T; Tei K; Hara A; Sawada H
Hinyokika Kiyo; 1986 Mar; 32(3):337-41. PubMed ID: 3728239
[TBL] [Abstract][Full Text] [Related]
5. [Detection of urinary polyamine by a new enzymatic differential assay. (I). Fundamental study on a new enzymatic differential assay].
Sakai S; Ito Y; Koide T; Tei K; Hara A; Sawada H
Hinyokika Kiyo; 1986 Mar; 32(3):327-36. PubMed ID: 3728238
[TBL] [Abstract][Full Text] [Related]
6. [Detection of polyamines by a new enzymatic differential assay. (8) Studies on tissue polyamine concentrations in patients with genitourinary malignant diseases].
Koide T; Sakai S; Kawada Y; Hara A; Sawada H
Hinyokika Kiyo; 1990 Oct; 36(10):1109-16. PubMed ID: 2264538
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
8. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
9. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
[TBL] [Abstract][Full Text] [Related]
11. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
12. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
13. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Kazama T; Katayama T; Yamazaki N
Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of cholesterol excretion in the urine].
Jüngst D; Osterholzer M; Lazik E; Karl HJ
Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
[TBL] [Abstract][Full Text] [Related]
15. Urine based markers of urological malignancy.
Konety BR; Getzenberg RH
J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
[TBL] [Abstract][Full Text] [Related]
16. [Detection of polyamines by a new enzymatic differential assay. (5). Studies on polyamine in the blood of patients with malignant genitourinary diseases].
Koide T; Sakai S; Shinoda I; Setsuda O; Tei KH; Hara A; Sawada H
Hinyokika Kiyo; 1986 Jul; 32(7):919-28. PubMed ID: 3776771
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of urinary ferritin, CEA and beta 2-MG determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):131-9. PubMed ID: 6375312
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
19. [TNM classification for urological cancer].
Kotake T
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2293-301. PubMed ID: 9881088
[TBL] [Abstract][Full Text] [Related]
20. [Urine levels of polyamine in patients with or without cancer].
Tsunoda A
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
